Q2 2016 Holdings
Filed 2016-08-15 | 7 holdings | $727.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-05-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | Common | 00287Y109 | $721.7M | 11,656,800 | 99.1% |
| Biogen Inc(BIIB) | Common | 09062X103 | $4.8M | 20,000 | 0.7% |
| Reynolds American Inc | Common | 761713106 | $502.8K | 9,322,463 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $360.3K | 10,304,751 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $325.7K | 7,535,533 | 0.0% |
| Theravance Biopharma Inc(TBPH) | Common | G8807B106 | $198.2K | 8,733,637 | 0.0% |
| Northwest Biotherapeutics Inc(NWBO) | Common | 66737P600 | $15.1K | 25,915,937 | 0.0% |